Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KLRF2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | AL513122.1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | RP11-212D19.4 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | FITM2 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
mRNA | C6orf1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | TSNAXIP1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | DEFB136 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | FAM210A | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | KCNK10 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | RIMS4 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |